122 related articles for article (PubMed ID: 28410808)
1. Questioning the differences between general public vs. patient based preferences towards EQ-5D-5L defined hypothetical health states.
Ogorevc M; Murovec N; Fernandez NB; Rupel VP
Health Policy; 2019 Feb; 123(2):166-172. PubMed ID: 28410808
[TBL] [Abstract][Full Text] [Related]
2. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
3. Public versus patient health preferences: protocol for a study to elicit EQ-5D-5L health state valuations for patients who have survived a stay in intensive care.
Halling CMB; Gudex C; Perner A; Jensen CE; Gyrd-Hansen D
BMJ Open; 2022 May; 12(5):e058500. PubMed ID: 35613809
[TBL] [Abstract][Full Text] [Related]
4. Patient and public preferences for health states associated with AMD.
Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
[TBL] [Abstract][Full Text] [Related]
5. DIFFERENTIATION OF HEALTH-RELATED QUALITY OF LIFE OUTCOMES BETWEEN FIVE DISEASE AREAS: RESULTS FROM AN INTERNATIONAL SURVEY OF PATIENTS.
Efthymiadou O; Mossman J; Kanavos P
Int J Technol Assess Health Care; 2018 Jan; 34(5):498-506. PubMed ID: 30251618
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Adult and Adolescent Preferences Toward EQ-5D-Y-3L Health States.
Prevolnik Rupel V; Ramos-Goñi JM; Ogorevc M; Kreimeier S; Ludwig K; Greiner W
Value Health; 2021 Sep; 24(9):1350-1359. PubMed ID: 34452716
[TBL] [Abstract][Full Text] [Related]
7. Parallel Valuation: A Direct Comparison of EQ-5D-3L and EQ-5D-5L Societal Value Sets.
Law EH; Pickard AS; Xie F; Walton SM; Lee TA; Schwartz A
Med Decis Making; 2018 Nov; 38(8):968-982. PubMed ID: 30403577
[TBL] [Abstract][Full Text] [Related]
8. Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods: Does Dimension Order Impact on Health State Values?
Mulhern B; Shah K; Janssen MF; Longworth L; Ibbotson R
Value Health; 2016; 19(2):210-7. PubMed ID: 27021755
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life measured using the EQ-5D-5L: South Australian population norms.
McCaffrey N; Kaambwa B; Currow DC; Ratcliffe J
Health Qual Life Outcomes; 2016 Sep; 14(1):133. PubMed ID: 27644755
[TBL] [Abstract][Full Text] [Related]
10. To What Extent Do Patient Preferences Differ From General Population Preferences?
Ludwig K; Ramos-Goñi JM; Oppe M; Kreimeier S; Greiner W
Value Health; 2021 Sep; 24(9):1343-1349. PubMed ID: 34452715
[TBL] [Abstract][Full Text] [Related]
11. Using Discrete Choice Experiments with Duration to Model EQ-5D-5L Health State Preferences.
Mulhern B; Bansback N; Hole AR; Tsuchiya A
Med Decis Making; 2017 Apr; 37(3):285-297. PubMed ID: 27681988
[TBL] [Abstract][Full Text] [Related]
12. EQ-5D-5L utilities per health states in Spanish population with knee or hip osteoarthritis.
García-Pérez L; Ramos-García V; Serrano-Aguilar P; Pais-Brito JL; Aciego de Mendoza M; Martín-Fernández J; García-Maroto R; Arenaza JC; Bilbao A
Health Qual Life Outcomes; 2019 Oct; 17(1):164. PubMed ID: 31666071
[TBL] [Abstract][Full Text] [Related]
13. An EQ-5D-5L value set based on Uruguayan population preferences.
Augustovski F; Rey-Ares L; Irazola V; Garay OU; Gianneo O; Fernández G; Morales M; Gibbons L; Ramos-Goñi JM
Qual Life Res; 2016 Feb; 25(2):323-333. PubMed ID: 26242249
[TBL] [Abstract][Full Text] [Related]
14. "The validity of the EQ-5D-5L in measuring quality of life benefits of breast reconstruction".
Kouwenberg CAE; Kranenburg LW; Visser MS; Busschbach JJ; Mureau MAM
J Plast Reconstr Aesthet Surg; 2019 Jan; 72(1):52-61. PubMed ID: 30270015
[TBL] [Abstract][Full Text] [Related]
15. The EQ-5D-5L Valuation study in Thailand.
Pattanaphesaj J; Thavorncharoensap M; Ramos-Goñi JM; Tongsiri S; Ingsrisawang L; Teerawattananon Y
Expert Rev Pharmacoecon Outcomes Res; 2018 Oct; 18(5):551-558. PubMed ID: 29958008
[TBL] [Abstract][Full Text] [Related]
16. Manipulating the 5 Dimensions of the EuroQol Instrument: The Effects on Self-Reporting Actual Health and Valuing Hypothetical Health States.
Tsuchiya A; Bansback N; Hole AR; Mulhern B
Med Decis Making; 2019 May; 39(4):379-392. PubMed ID: 31161860
[No Abstract] [Full Text] [Related]
17. Is bad living better than good death? Impact of demographic and cultural factors on health state preference.
Jin X; Liu GG; Luo N; Li H; Guan H; Xie F
Qual Life Res; 2016 Apr; 25(4):979-86. PubMed ID: 26346987
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population.
Juanbeltz R; Castilla J; Martínez-Baz I; O'Leary A; Sarobe M; San Miguel R
Qual Life Res; 2019 Jun; 28(6):1477-1484. PubMed ID: 30666549
[TBL] [Abstract][Full Text] [Related]
19. Which approach is better in eliciting health state utilities from breast cancer patients? Evidence from mainland China.
Li S; Wang M; Liu L; Chen G
Eur J Cancer Care (Engl); 2019 Mar; 28(2):e12965. PubMed ID: 30499193
[TBL] [Abstract][Full Text] [Related]
20. Time trade-off and ranking exercises are sensitive to different dimensions of EQ-5D health states.
Rand-Hendriksen K; Augestad LA
Value Health; 2012; 15(5):777-82. PubMed ID: 22867789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
